U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07452432) titled 'Korean Prospective Upper Tract Urothelial Carcinoma Cohort' on Feb. 28.
Brief Summary: This is a single-center, prospective, non-interventional observational cohort study designed to establish a structured recurrence monitoring platform in Korean patients with high-grade non-metastatic upper tract urothelial carcinoma (UTUC).
Eligible adult patients scheduled to receive neoadjuvant chemotherapy followed by radical nephroureterectomy will undergo circulating tumor DNA (ctDNA) sampling prior to chemotherapy initiation and once between 1-6 months after surgery.
Clinical, imaging, pathological, and longitudinal follow-up data will be ...